The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM)
Acta Diabetologica, 04/03/2012
Sartore G et al. – HbA1c levels identify states of sustained hyperglycemia and seem to be unaffected by hypoglycemic episodes or short–lived glucose spikes, consequently revealing shortcomings as a “gold standard” indicator of metabolic control. Glucose variability indicators describe the glucose profile of type 1 diabetic patients and identify any worsening glycemic control (typical of longstanding diabetes) more accurately than HbA1c tests.
The study involved 68 patients divided into 3 groups as follows: 35 patients had type 1 diabetes (group 1); 17 had type 2 diabetes and were taking multiple daily injections (MDI) of insulin (group 2); and 16 patients had type 2 diabetes treated with OHA and/or basal insulin (group 3).
The indicators were obtained over at least 48 h using a continuous glucose monitoring (CGM) system.
HbA1c levels were measured at the baseline and after CGM.
HbA1c correlated significantly with AG (r = 0.74), AUC PP (r = 0.69) and HBGI (r = 0.74), but only in type 1 diabetic patients.
Patients with longstanding disease and type 1 diabetes had a greater glucose variability, irrespective of their HbA1c levels.
Insulin therapy with MDI correlated strongly with HbA1c, but not with glucose variability.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.